Y-mabs Therapeutics Share Price (NASDAQ: YMAB)
$8.55
▲
0.01
(0.12%)
Last updated on
Check the interactive Y-mabs Therapeutics Stock chart to analyse performance
Y-mabs Therapeutics stock performance
as on August 30, 2025 at 1:29 am IST
- Today's Low:$8.54Today's High:$8.55
0.12%
Downside
Day's Volatility :0.12%
Upside
0.0%
- 52 Weeks Low:$3.5552 Weeks High:$16.11
58.48%
Downside
52 Weeks Volatility :77.96%
Upside
46.93%
Y-mabs Therapeutics Stock Returns
Y-mabs Therapeutics Inc. Key Stats
Check Y-mabs Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Y-mabs Therapeutics Stock including INR - Dollar returns
The Y-mabs Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Y-mabs Therapeutics investment value today
Current value as on today
₹66,884
Returns
Returns from Y-mabs Therapeutics Stock
Dollar Returns*
₹5,284 (+5.28%)
Indian investors sentiment towards Y-mabs Therapeutics Stock
Global Institutional Holdings in Y-mabs Therapeutics Inc.
Name
Holdings %
Paradigm Biocapital Advisors LP
9.32%
BlackRock Inc
6.39%
Caligan Partners LP
5.16%
Sofinnova Ventures
4.83%
Vanguard Group Inc
4.28%
Polar Capital Holdings PLC
4.03%
Analyst Recommendation on Y-mabs Therapeutics Stock
Buy
76%Buy
15%Hold
7%Sell
Based on 13 Wall street analysts offering stock ratings for Y-mabs Therapeutics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Y-mabs Therapeutics Share Price Target
What analysts predicted
Upside of 0.58%
Target:
$8.60
Current:
$8.55
Y-mabs Therapeutics share price target is $8.60, a slight Upside of 0.58% compared to current price of $8.55 as per analysts' prediction.
Y-mabs Therapeutics Stock Insights
Price Movement
In the last 1 month, YMAB stock has moved up by 78.4%Decreasing Revenue
Revenue is down for the last 3 quarters, 26.49M → 19.52M (in $), with an average decrease of 13.9% per quarterIncreasing Net Profit
Netprofit is up for the last 5 quarters, -9.24M → -3.23M (in $), with an average increase of 31.6% per quarterYMAB vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 110.2%YMAB vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 157.6%Price to Sales
ForYMAB every $1 of sales, investors are willing to pay $4.5, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.
Y-mabs Therapeutics Technicals Summary
Sell
Neutral
Buy
Y-mabs Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Y-mabs Therapeutics Inc. Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| 88.63% | 64.64% | -38.44% | -46.63% | -79.01% |
 | 6.48% | -15.2% | -50.31% | -3.3% | -2.01% |
 | 1.77% | 24.81% | 62.78% | 79.11% | 29.69% |
 | -14.45% | -19.13% | -17.84% | 34.68% | 41.87% |
 | 13.79% | 83.28% | 75.87% | 111.28% | 242.25% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | NA | -0.84 | -0.24 | -0.09 | NA | 1.93 |
| 14.6 | 14.6 | 1.2 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.73 | -0.05 | -0.01 | NA | 34.32 |
| 27.86 | 27.86 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $388.5M | -79.01% | NA | -26.03% |
| Buy | $61.4B | -2.01% | 14.6 | 31.37% |
| NA | $36.5B | 29.69% | NA | -3.89% |
| Buy | $100.5B | 41.87% | 27.86 | 31.86% |
| Buy | $59.5B | 242.25% | NA | -12.96% |
About Y-mabs Therapeutics Inc.
Key Management of Y-mabs Therapeutics Inc.
Important FAQs about investing in YMAB Stock from India :
What is Y-mabs Therapeutics share price today?
Y-mabs Therapeutics share price today is $8.55 as on at the close of the market. Y-mabs Therapeutics share today touched a day high of $8.55 and a low of $8.54.
What is the 52 week high and 52 week low for Y-mabs Therapeutics share?
Y-mabs Therapeutics share touched a 52 week high of $16.11 and a 52 week low of $3.55. Y-mabs Therapeutics stock price today i.e. is closed at $8.55, lower by 46.93% versus the 52 week high.
How to invest in Y-mabs Therapeutics Stock (YMAB) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Y-mabs Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Y-mabs Therapeutics Shares that will get you 0.1754 shares as per Y-mabs Therapeutics share price of $8.55 per share as on August 30, 2025 at 1:29 am IST.
What is the minimum amount required to buy Y-mabs Therapeutics Stock (YMAB) from India?
Indian investors can start investing in Y-mabs Therapeutics (YMAB) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Y-mabs Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025).
Based on Y-mabs Therapeutics share’s latest price of $8.55 as on August 30, 2025 at 1:29 am IST, you will get 1.1696 shares of Y-mabs Therapeutics. Learn more about
fractional shares .
What are the returns that Y-mabs Therapeutics has given to Indian investors in the last 5 years?
Y-mabs Therapeutics stock has given -79.01% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
- Webs Defined Volatility Xle
$24.99
-0.04%
- United States 12 Month Natur
$7.81
+1.83%
- F/m U S T Inl-p S (tips) Etf
$50.14
+0.06%
- Pgim Jennison Focused Growth Etf
$105.89
-1.37%
Hitek Global Inc$1.49
+1.36%
Vaneck Vectors Preferred Secs Ex Finls Etf$17.68
-0.73%
Marker Therapeutics Inc$0.93
+3.33%
Grupo Aval Acciones Y Valores S.a.$3.33
-0.89%